Study Designed to Optimize the Treatment of Primary Pneumothorax (TOPP)
Primary Spontaneous Pneumothorax, Pleural Disease
About this trial
This is an interventional treatment trial for Primary Spontaneous Pneumothorax focused on measuring primary spontaneous pneumothorax, epidemiology, genetics, risk factors
Eligibility Criteria
Inclusion Criteria:
- First incidence of primary spontaneous pneumothorax.
- Age between 18 and 40.
- No known preexisting pulmonary disease.
- Patient must accept randomization.
- Able to read and understand information regarding the study.
- The condition must require treatment with a chest-tube.
Exclusion Criteria:
- Age above 40.
- Previously pulmonary og cardiac surgery.
- Pregnant or breastfeeding.
- Patients who do not tolerate anesthetics.
Sites / Locations
- Research Unit at the cardiothoracic departement at the University Hospital of OdenseRecruiting
- Research Unit at the Cardiothoracic Department at the University Hospital of SkejbyRecruiting
- Research Unit at the Cardiothoracic Department af Ålborg HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
HRCT with bullae, treatment conservative
HRCT no bullae, treatment conservative
HRCT with bullae, treatment VATS.
HRCT no bullae, treatment VATS.
Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to conservative treatment with conventional chest-tube drainage.
Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to conservative treatment with conventional chest-tube drainage.
Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.
Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.